Today: 17 March 2026
Barclays share price hits fresh 52-week high after buyback ends as BoE, results loom
3 February 2026
1 min read

Barclays share price hits fresh 52-week high after buyback ends as BoE, results loom

London, Feb 3, 2026, 08:21 GMT — Regular session

  • Barclays shares climbed roughly 0.6% in early trading, hitting a new 52-week high for a moment.
  • The bank confirmed it has wrapped up a share buyback totaling about £500 million, a move that has bolstered the stock in recent months.
  • Attention turns to the Bank of England’s Feb. 5 decision, with Barclays set to report full-year results on Feb. 10.

Barclays shares crept up in early London trading on Tuesday, building on a rally that drove the stock to a new 52-week peak. By 08:21 GMT, the price stood at 502.3 pence, having briefly hit 503.7 pence. London South East

The move arrives as investors mull the bank’s next steps on capital returns, with the latest buyback wrapped up and earnings just days off. It’s also a week packed with key UK macro cues for lenders, kicking off with the central bank on Thursday.

Barclays confirmed on Monday it wrapped up the share buyback announced on Oct. 23, 2025, repurchasing a total of 107,319,865 shares for roughly £500 million. The bank said the volume-weighted average price paid was 465.8970 pence per share and that it will cancel all the shares it bought. London South East

In a separate announcement, the bank confirmed that 7,127,204 ordinary shares have been admitted to trading on the main market of the London Stock Exchange, pushing the total number of admitted shares to 13,815,647,298. Investegate

The broader backdrop lent support. European banking stocks took the lead on Monday, climbing 2% to hit their highest point since 2008, even after an early shakeup from commodity volatility. “Europe came in with a much more positive tone,” noted Steve Sosnick, chief market analyst at Interactive Brokers. Reuters

All eyes in the UK are now fixed on the Bank of England, set to announce its policy decision Thursday, Feb. 5. Most economists surveyed by Reuters predict the MPC will keep rates steady at 3.75%. One analyst even dubbed the meeting “boring” — which might actually soothe risk appetite. Mohamad Al-Saraf from Danske Bank said he doesn’t expect much market movement. Reuters

Bank stocks hinge on rate expectations, which shape investor views on lending profits. One crucial metric is net interest margin — the spread between earnings on loans and costs of deposits — and it can shrink if markets begin anticipating faster rate cuts.

Barclays will release its final results on Feb. 10, with investors keen to hear updates on capital return plans and insights from its investment bank amid changing dealmaking and trading landscapes. London South East

The near-term outlook isn’t without risk. If the central bank delivers a more dovish message than anticipated, or if rates markets suddenly shift, the sector could take a quick hit. On Feb. 10, any cautious remarks from management might put pressure on a stock that’s currently trading near multi-month highs.

Stock Market Today

  • Velan Inc. Stock Falls Below 200-Day Moving Average Amid Heavy Trading
    March 17, 2026, 4:47 AM EDT. Velan Inc. (TSE:VLN) shares dropped below their 200-day moving average of C$16.52 on Monday, trading as low as C$15.50 before closing at C$16.10 with a volume of 1,594 shares. This technical indicator suggests possible downward momentum. The company, specializing in industrial valve manufacturing for sectors like oil, gas, and power generation, holds a market cap of C$347.53 million and a price-to-earnings ratio of 5.33. Analysts currently maintain a Hold rating on Velan, as other stocks in the market are considered stronger buys. The move below the 200-day average reflects cautious investor sentiment despite Velan's solid balance sheet ratios, including a quick ratio of 1.11 and current ratio of 2.34.
GSK share price nears a one-year high ahead of earnings after Wave drug handback and R&D cuts
Previous Story

GSK share price nears a one-year high ahead of earnings after Wave drug handback and R&D cuts

Experian PLC share price falls as buyback starts to show up in the tape
Next Story

Experian PLC share price falls as buyback starts to show up in the tape

Go toTop